Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

A Decade of Anti-Myeloma Vaccine Development through Early Phase Trials: A Systematic Review

Nadia Carenina Nunes Cavalcante Parr, MD, Muhammad Junaid Tariq, MD, Muhammad Usman, MD, Muhammad Asad Fraz, MD, Ali Younas Khan, MD, Sharoon Samuel, MBBS, Awais Ijaz, MD, Malik Qistas Ahmad, MD MBBS, Muhammad Jahanzeb Khalil, MD, Muhammad Yasir, MD, Saher Nasir Amin, MD, Ahmad Safdar, Abdul Rafae, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 5635.

https://doi.org/10.1182/blood-2018-99-115922

Published: 2018

Journal Articles

Immunotoxin Targeting Cell-Bound MUC1 on Myelomonocytic and Monocytic Leukemic Cells

Thierry Guillaume, MD PhD, Virginie Dehame, MSc, Patrice Chevallier, MD, Pierre Peterlin, MD, Marc Gregoire, PhD, Daniel Rubinstein, MD, Eddy Pichinuk, PhD, Daniel H Wreschner, MD

Blood (2017) 130 (Supplement 1): 5060.

https://doi.org/10.1182/blood.V130.Suppl_1.5060.5060

Published: 2017

Journal Articles

Striking a chord

Juli-Anne Gardner, Katherine A. Devitt

Blood (2017) 130 (18): 2043.

https://doi.org/10.1182/blood-2017-07-796904

Published: 2017

Journal Articles

MUC1-C Inhibition Leads to Decrease in PD-L1 Levels Via up-Regulation of Micro RNAs

Blood (2016) 128 (22): 2871.

https://doi.org/10.1182/blood.V128.22.2871.2871

Published: 2016

Journal Articles

Tumor Markers in Diagnosis and Follow up of Haematologic Malignancies

Zisis Kontoninas, MD PhD, Georgia D Kaiafa, MD PhD, Zoi Saouli, MD PhD Haematologist, Christos G Savopoulos, Associate Prof of Internal MDcine, Didangelos Triantafyllos, Assistant Prof of Internal MDcine, Achilles Anagnostopoulos, Apostolos I Hatzitolios, Professor of Internal MDcine, Athanasios Papadopoulos, Professor of Haematology

Blood (2016) 128 (22): 5337.

https://doi.org/10.1182/blood.V128.22.5337.5337

Published: 2016

Journal Articles

A Novel Dendritic Cell-Derived Vaccine in Multiple Myeloma

Rebecca Karp Leaf, MD, Dina Stroopinsky, PhD, Athalia Rachel Pyzer, MD, Ada M. Kruisbeek, PhD, Sandra Van Wetering, PhD, Abigail J. Washington, BA, Leandra Cole, BA, Myrna R. Nahas, MD, Salvia Jain, MD, Arie Apel, MD, Jon Arnason, MD, Ayad Hamdan, MD, Jacalyn Rosenblatt, MD, David E. Avigan, MD

Blood (2016) 128 (22): 4484.

https://doi.org/10.1182/blood.V128.22.4484.4484

Published: 2016

Journal Articles

MUC-1 Regulates MiR34a Expression in Acute Myeloid Leukemia Cells Resulting in an Accumulation of Granulocytic Myeloid-Derived Suppressor Cells

Blood (2015) 126 (23): 643.

https://doi.org/10.1182/blood.V126.23.643.643

Published: 2015

Journal Articles

Long Term Update on Phase I/II Trial with Immucin Anti-MUC1 Signal Peptide Vaccine for Multiple Myeloma Patients with Residual Disease or Progression

Lior Carmon, PhD, Irit Avivi, Riva Kovjazin, Lillian Dary, Michael Y Shapira, MD

Blood (2014) 124 (21): 4768.

https://doi.org/10.1182/blood.V124.21.4768.4768

Published: 2014

Journal Articles

Phase I/II Trial Of Immucin a Pan HLA, Anti-MUC1 Signal Peptide Vaccine, In Multiple Myeloma Patients With Residual Disease Or Progression Following Autologous Stem Cell Transplantation

Lior Carmon, PhD, Irit Avivi, MD, Kovjazin Riva, MD, Lillian Dary, Michael Y Shapira, MD

Blood (2013) 122 (21): 1943.

https://doi.org/10.1182/blood.V122.21.1943.1943

Published: 2013

Journal Articles

Boost and Loss Of Immune Responses Against Tumor-Associated Antigens In The Course Of Pregnancy As a Model For Immunotherapy

Mathias Lutz, Medical Student, Miriam Alb, MSc, Andrea Worschech, PhD, Sabine Gahn, MLS, Laura Bernhard, MLS, Michael Schwab, MD, Hermann Einsele, MD, Ulrike Kämmerer, PhD, Peter Heuschmann, MD, Erdwine Klinker, MD, Christoph Otto, PhD, Stephan Mielke, MD

Blood (2013) 122 (21): 4505.

https://doi.org/10.1182/blood.V122.21.4505.4505

Published: 2013

Journal Articles

Multicentric Castleman Disease with Complete Duodenal Obstruction in an HIV Patient

Tarsheen K Sethi, Abdolmohammadi Alireza, Goetz H Kloecker, MD, Stephen P Slone

Blood (2012) 120 (21): 4834.

https://doi.org/10.1182/blood.V120.21.4834.4834

Published: 2012

Journal Articles

Immune Responses Against the Tumor-Associated Antigens WT1, MUC-1, PRAME and HER2/Neu in 114 Prospectively Screened Healthy Donors: Effects of Gender and Prior Pregnancy and Implications for Immunotherapy

Mathias Lutz, Andrea Worschech, PhD, Sabine Gahn, MLS, Laura Bernhard, MLS, Michael Schwab, MD, Hermann Einsele, MD, Ulrike Kämmerer, PhD, Peter Heuschmann, MD, Erdwine Klinker, MD, Christoph Otto, PhD, Stephan Mielke, MD

Blood (2012) 120 (21): 4115.

https://doi.org/10.1182/blood.V120.21.4115.4115

Published: 2012

Journal Articles

Anaplastic Lymphoma Kinase (ALK)-Positive Diffuse Large B-Cell Lymphoma Presenting with CNS Involvement: A Case Report

Blakely D Kute, MD, Aaron Spalding, MD, PhD, Alvin W. Martin, MD, David Sun, MD, PhD

Blood (2011) 118 (21): 5225.

https://doi.org/10.1182/blood.V118.21.5225.5225

Published: 2011

Journal Articles

Implication of Tissue-Factor Bearing Microparticles In Thrombosis Associated with Breast Cancer

François Mullier, Damien Gheldof, Severine Robert, Nicolas Bailly, Philippe Devel, Chantal Doyen, Christian Chatelain, Carine Michiels, Bernard Chatelain, Jean-Michel Dogné

Blood (2010) 116 (21): 3165.

https://doi.org/10.1182/blood.V116.21.3165.3165

Published: 2010

Journal Articles

Vector Prime-Protein Boost Vaccine Induces 20 Fold Decrease in the Levels of CD44 + CD24 −/Low Cancer Stem Cells in Epithelial Neoplasms

Yucheng Tang, MD, PhD, Hakan Akbulut, MD, Jonathan Maynard, Pingchaun Li, PhD, Albert B. Deisseroth, MD, PhD

Blood (2008) 112 (11): 2908.

https://doi.org/10.1182/blood.V112.11.2908.2908

Published: 2008

Journal Articles

Development of Venous Thromboembolic Events in Cancer Patients with Elevated Levels of Tissue Factor-Bearing Microparticles

Jeffrey Zwicker, M.D., Howard A. Liebman, MA, MD, Donna Neuberg, ScD, Kenneth Bauer, M.D., Furie Barbara, PhD, Furie Bruce, M.D.

Blood (2008) 112 (11): 3832.

https://doi.org/10.1182/blood.V112.11.3832.3832

Published: 2008

Journal Articles

A Novel Hodgkin Lymphoma Cell Line (KHL) Established from An Untreated Patient.

Ta-Chih Liu, Yuan-Shiang Kao, Rachael Demuth, Nina Mathews, Carmen Espinoza, Jan-Gowth Chang

Blood (2008) 112 (11): 1448.

https://doi.org/10.1182/blood.V112.11.1448.1448

Published: 2008

Journal Articles

Targeting MUC1 as a Marker for Myeloid Leukemia Stem Cells by DC/AML Fusions.

Jacalyn Rosenblatt, MD, Zekui Wu, MD, Corrine Lenahan, MD, Adam Bissonnette, Baldev Vasir, PhD, Kenneth Miller, MD, Robin Joyce, MD, James Levine, MD, Ilene Galinsky, RN, Richard Stone, MD, Donald Kufe, MD, David Avigan, MD

Blood (2007) 110 (11): 1794.

https://doi.org/10.1182/blood.V110.11.1794.1794

Published: 2007

Journal Articles

Stimulation of Anti-Tumor Immunity Using Dendritic Cells Transduced with Fowl Pox Vector Expressing MUC-1 and Costimulatory Molecules (PANVAC-F).

Baldev Vasir, PhD, Corrine Lenahan, MD, Jacalyn Rosenblatt, MD, Adam Bissonnette, Zekui Wu, MD, Donald Kufe, MD, David Avigan, MD

Blood (2006) 108 (11): 5209.

https://doi.org/10.1182/blood.V108.11.5209.5209

Published: 2006

Journal Articles

Ca 15-3 a Marker for the Megaloblastic Anaemia?.

Vincenzo Mettivier, MD, Luca Pezzullo, MD, Olimpia Finizio, MD, Stefano Rocco, MD, Lucia Bene, MD, Carlo De Rosa, MD

Blood (2005) 106 (11): 3733.

https://doi.org/10.1182/blood.V106.11.3733.3733

Published: 2005

NARROW

A Decade of Anti-Myeloma Vaccine Development through Early Phase Trials: A Systematic Review

Immunotoxin Targeting Cell-Bound MUC1 on Myelomonocytic and Monocytic Leukemic Cells

Striking a chord

MUC1-C Inhibition Leads to Decrease in PD-L1 Levels Via up-Regulation of Micro RNAs

Tumor Markers in Diagnosis and Follow up of Haematologic Malignancies

A Novel Dendritic Cell-Derived Vaccine in Multiple Myeloma

MUC-1 Regulates MiR34a Expression in Acute Myeloid Leukemia Cells Resulting in an Accumulation of Granulocytic Myeloid-Derived Suppressor Cells

Long Term Update on Phase I/II Trial with Immucin Anti-MUC1 Signal Peptide Vaccine for Multiple Myeloma Patients with Residual Disease or Progression

Phase I/II Trial Of Immucin a Pan HLA, Anti-MUC1 Signal Peptide Vaccine, In Multiple Myeloma Patients With Residual Disease Or Progression Following Autologous Stem Cell Transplantation

Boost and Loss Of Immune Responses Against Tumor-Associated Antigens In The Course Of Pregnancy As a Model For Immunotherapy

Multicentric Castleman Disease with Complete Duodenal Obstruction in an HIV Patient

Immune Responses Against the Tumor-Associated Antigens WT1, MUC-1, PRAME and HER2/Neu in 114 Prospectively Screened Healthy Donors: Effects of Gender and Prior Pregnancy and Implications for Immunotherapy

Anaplastic Lymphoma Kinase (ALK)-Positive Diffuse Large B-Cell Lymphoma Presenting with CNS Involvement: A Case Report

Implication of Tissue-Factor Bearing Microparticles In Thrombosis Associated with Breast Cancer

Vector Prime-Protein Boost Vaccine Induces 20 Fold Decrease in the Levels of CD44 + CD24 −/Low Cancer Stem Cells in Epithelial Neoplasms

Development of Venous Thromboembolic Events in Cancer Patients with Elevated Levels of Tissue Factor-Bearing Microparticles

A Novel Hodgkin Lymphoma Cell Line (KHL) Established from An Untreated Patient.

Targeting MUC1 as a Marker for Myeloid Leukemia Stem Cells by DC/AML Fusions.

Stimulation of Anti-Tumor Immunity Using Dendritic Cells Transduced with Fowl Pox Vector Expressing MUC-1 and Costimulatory Molecules (PANVAC-F).

Ca 15-3 a Marker for the Megaloblastic Anaemia?.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only